WHO guideline for adults with obesity: conditional recommendations for long-term GLP-1 therapies, and for combining them with intensive behavioural therapy, citing limited long-term data, cost, equity and health-system readiness.
Guideline
Celletti et al. World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults